FINANCIALS

CRSP Crispr Therapeutics Ag 1674416

Income Statement
Revenue	crsp-20241231	37,314,000
Net Income	crsp-20241231	-366,252,000
Profit Margin		-981.54%

Balance Sheet
Current Assets	1,937,132,000
Assets	2,242,034,000
Current Liabilities	87,782,000
Liabilities	309,954,000
Equity	1,932,080,000
Shares Out	85,168,000

Cash Flow Statement
Operating Cash Flow	-142,774,000
Investing Cash Flow	-280,481,000

Market Analysis
Market Cap	4,237,115,960
Price	41.83
BVPS	22.69
PB	1.84
EPS	-3.21
PS	28.39
FCF	-423,255,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view CRSP documents filed with the SEC.

CRSP Filings Clear

View A List of Tickers